Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 4.01M | 4.01M | 10.03M | 99.47K | 248.47K | 369.64K |
Gross Profit | 386.94K | 386.94K | ― | 98.53K | 247.22K | 368.58K |
EBITDA | -3.03M | -3.03M | ― | -631.08K | -495.71K | -1.24M |
Net Income | -3.86M | -3.86M | ― | -826.96K | -794.51K | -1.46M |
Balance Sheet | ||||||
Total Assets | 5.61M | 5.61M | 11.56M | 9.27M | 9.75M | 10.01M |
Cash, Cash Equivalents and Short-Term Investments | 598.22K | 598.22K | 2.55M | 5.18M | 6.64M | 723.94K |
Total Debt | 2.07M | 2.07M | 2.71M | 2.28M | 138.15K | 1.58M |
Total Liabilities | 3.57M | 3.57M | 5.07M | 2.81M | 2.47M | 2.09M |
Stockholders Equity | 3.71M | 3.71M | 7.49M | 6.45M | 7.28M | 7.92M |
Cash Flow | ||||||
Free Cash Flow | -1.33M | -1.33M | -938.34K | ― | 5.92M | -3.05M |
Operating Cash Flow | -926.70K | -926.70K | -765.73K | -1.56M | 5.92M | -3.05M |
Investing Cash Flow | -440.87K | -440.87K | -383.10K | ― | ― | 0.00 |
Financing Cash Flow | -560.51K | -560.51K | -126.26K | ― | -4.18K | 26.92K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
51 Neutral | $8.02B | -0.39 | -43.38% | 2.20% | 22.34% | -2.13% | |
40 Underperform | C$1.39M | ― | -21.61% | ― | ― | ― | |
― | C$1.96M | ― | ― | ― | ― | ||
― | $2.37M | ― | ― | ― | ― | ||
― | $1.91M | ― | ― | ― | ― | ||
49 Neutral | C$375.91K | ― | -542.08% | ― | -100.00% | 43.66% | |
31 Underperform | C$2.42M | ― | ― | 563.34% | -68.82% |
Vencanna Ventures reported its interim financial results for the three months ending January 31, 2025, highlighting a strategic shift following its acquisition of The Cannavative Group. The company has been focusing on operational efficiencies and cost reductions, including moving to a smaller facility in Nevada to better align with its product focus on pre-rolls. In New Jersey, Vencanna is advancing its presence with new cultivation and retail sites. Despite a decrease in revenue, the company achieved a higher gross profit due to reduced costs, although it reported a comprehensive loss primarily due to expenses related to the Cannavative acquisition and facility relocation.